- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | Custom Health Holdings Inc. GAAP EPS of $1.29, revenue of $7.38M | 1 | Seeking Alpha | ||
| CUSTOM HEALTH Aktie jetzt für 0€ handeln | |||||
| 18.08. | Custom Health Holdings Inc.: Custom Health Achieves 70% Increase in Quarterly Revenue in Q2-2026 and Advances Medication Management Platform with Evergreen Pharmacy and Spencer Health Solutions Acquisitions | 657 | Newsfile | For the three months ended June 30, 2026, Custom Health achieved quarterly revenue of US$7.4 million, an increase of 70% from Q2-2025. The results reflect the acquisition of InnovativeRx during... ► Artikel lesen | |
| 05.08. | Custom Health Holdings Inc: Custom Health enters deal to acquire Spencer Health | 1 | Stockwatch | ||
| 05.08. | Custom Health Holdings Inc.: Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home | 655 | Newsfile | Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer... ► Artikel lesen | |
| 22.07. | Custom Health Holdings Inc: Custom Health agrees to buy Evergreen pharmacy | 1 | Stockwatch | ||
| 22.07. | Stocks in Play: Custom Health Holdings Inc | 1 | Baystreet.ca | ||
| 22.07. | Custom Health to acquire Evergreen Pharmacy for $3.5M | 3 | Seeking Alpha | ||
| 22.07. | Custom Health Holdings Inc.: Custom Health Announces Binding Letter of Intent to Acquire Evergreen Pharmacy; Expected to Add Over US$78 Million in Annual Revenue | 565 | Newsfile | Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex... ► Artikel lesen | |
| 08.07. | Custom Health: Delivering Healthcare Through AI-Enabled Technology | 1 | The Market Online Canada | ||
| 03.07. | Custom Health Holdings Inc: Custom Health loses $8.05-million (U.S.) in Q1 | 3 | Stockwatch | ||
| 03.07. | Stocks in Play: Custom Health Holdings Inc. | 1 | Baystreet.ca | ||
| 03.07. | Custom Health Holdings Inc.: Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026 | 733 | Newsfile | For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million,... ► Artikel lesen | |
| 25.06. | Custom Health Holdings Inc: Custom Health appoints Guzman chief compliance officer | 1 | Stockwatch | ||
| 25.06. | Custom Health Holdings Inc.: Custom Health Announces Strategic Leadership Appointments to Support Continued Growth and Regulatory Excellence | 469 | Newsfile | Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's... ► Artikel lesen | |
| 23.06. | Custom Health Holdings Inc: Custom Health Holdings to trade on TSX | 1 | Stockwatch | ||
| 23.06. | Custom Health Holdings Inc: Custom Health Holdings to trade on TSX June 24 | 1 | Stockwatch | ||
| 22.06. | Custom Health Holdings Inc.: Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange | 1.236 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Custom Health Holdings Inc. (TSX: CHLT) (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release... ► Artikel lesen | |
| 10.06. | Custom Health Holdings Inc.: Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America | 733 | Newsfile | Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US Holdings, Inc. ("InnovativeRx") to expand its integrated... ► Artikel lesen | |
| 09.06. | Kevin Knight: Kevin Knight - Early Warning Regarding Acquisition of Common Shares of Custom Health Holdings Inc | 320 | Newsfile | This press release is issued pursuant to National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider... ► Artikel lesen | |
| 06.06. | Custom Health Holdings Inc. Announces Completion of Plan of Arrangement | 960 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Custom Health Holdings Inc. (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated May... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,295 | -1,35 % | AKTIEN IM FOKUS: Zinsanstieg birgt Gefahren für sichere Aktienhäfen | FRANKFURT (dpa-AFX) - Steigende Zinsen an den Kapitalmärkten haben zum Wochenbeginn die Aktienkurse von als sichere Anlagen geltenden Unternehmen belastet. Dazu zählen unter anderen die Immobilienwerte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,280 | +1,61 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,620 | +0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 99,50 | 0,00 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| HEARTFLOW | 48,880 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,530 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,75 | +0,03 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| GERRESHEIMER | 29,840 | +1,51 % | PRESSESPIEGEL/Unternehmen: VOLKSWAGEN, BERTELSMANN, GERRESHEIMER, GLENCORE/RADIANT, AIRBUS | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
VOLKSWAGEN - Im Machtkampf um das nächste Sanierungspaket bei Volkswagen... ► Artikel lesen | |
| SANARA MEDTECH | 34,740 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,790 | +0,13 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 19,410 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,580 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,140 | -1,87 % | EQS-DD: Carl Zeiss Meditec AG: Justus Felix Wehmer, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.09.2026 / 17:25... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,730 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 25,930 | 0,00 % | Progyny stock price target maintained at $31 by Citizens on new offering |
CUSTOM HEALTH HOLDINGS INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CUSTOM HEALTH HOLDINGS INC finden Sie auf Wallstreet Online.